83 FR 24803 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 104 (May 30, 2018)

Page Range		24803-24803
FR Document		2018-11560

Federal Register, Volume 83 Issue 104 (Wednesday, May 30, 2018)

[Federal Register Volume 83, Number 104 (Wednesday, May 30, 2018)]
[Notices]
[Page 24803]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-11560]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; NIDDK Clinical Trials in 
Diabetes.
    Date: June 18, 2018.
    Time: 9:00 a.m. to 10:00 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Elena Sanovich, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7351, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, 301-
594-8886, sanoviche@mail.nih.gov.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; PAR-18-042: Ancillary 
Studies to Major Ongoing Clinical Research Studies.
    Date: June 28, 2018.
    Time: 10:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Dianne Camp, Ph.D., Scientific Review Officer, 
Review Branch, DEA, NIDDK, National Institutes of Health, Room 7013, 
6707 Democracy Boulevard, Bethesda, MD 20892-2542, 301-594-7682, 
campd@extra.niddk.nih.gov.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; PAR-18-423: NIDDK Multi-
Center Clinical Study Implementation Planning Cooperative Agreements 
(U34 Clinical Trial Optional).
    Date: July 2, 2018.
    Time: 11:30 a.m. to 2:00 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Najma S. Begum, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7349, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 
594-8894, begumn@niddk.nih.gov.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Lymphatics in Health and 
Disease.
    Date: July 17, 2018.
    Time: 10:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Michele L. Barnard, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7353, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, (301) 
594-8898, barnardm@extra.niddk.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: May 24, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-11560 Filed 5-29-18; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 83, No. 104 / Wednesday, May 30, 2018 / Notices 24803

responsible for making sure that your DEPARTMENT OF HEALTH AND Place: National Institutes of Health, Two
comment does not include any sensitive HUMAN SERVICES Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
health information, such as medical
National Institutes of Health Conference Call).
records or other individually Contact Person: Najma S. Begum, Ph.D.,
identifiable health information. In Scientific Review Officer, Review Branch,
National Institute of Diabetes and
addition, your comment should not DEA, NIDDK, National Institutes of Health,
Digestive and Kidney Diseases; Notice Room 7349, 6707 Democracy Boulevard,
include any ‘‘trade secret or any of Closed Meetings
commercial or financial information Bethesda, MD 20892–5452, (301) 594–8894,
Pursuant to section 10(d) of the begumn@niddk.nih.gov.
which . . . is privileged or
Federal Advisory Committee Act, as Name of Committee: National Institute of
confidential’’—as provided by Section Diabetes and Digestive and Kidney Diseases
6(f) of the FTC Act, 15 U.S.C. 46(f), and amended, notice is hereby given of the
Special Emphasis Panel; Lymphatics in
FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)— following meetings. Health and Disease.
including in particular competitively The meetings will be closed to the Date: July 17, 2018.
sensitive information such as costs, public in accordance with the Time: 10:00 a.m. to 2:00 p.m.
sales statistics, inventories, formulas, provisions set forth in sections Agenda: To review and evaluate grant
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., applications.
patterns, devices, manufacturing Place: National Institutes of Health, Two
as amended. The grant applications and
processes, or customer names. Democracy Plaza, 6707 Democracy
the discussions could disclose
Comments containing material for confidential trade secrets or commercial Boulevard, Bethesda, MD 20892 (Telephone
which confidential treatment is Conference Call).
property such as patentable material, Contact Person: Michele L. Barnard, Ph.D.,
requested must be filed in paper form, and personal information concerning Scientific Review Officer, Review Branch,
must be clearly labeled ‘‘Confidential,’’ individuals associated with the grant DEA, NIDDK, National Institutes of Health,
and must comply with FTC Rule 4.9(c). applications, the disclosure of which Room 7353, 6707 Democracy Boulevard,
In particular, the written request for would constitute a clearly unwarranted Bethesda, MD 20892–2542, (301) 594–8898,
confidential treatment that accompanies invasion of personal privacy. barnardm@extra.niddk.nih.gov.
the comment must include the factual Name of Committee: National Institute of (Catalogue of Federal Domestic Assistance
and legal basis for the request, and must Diabetes and Digestive and Kidney Diseases Program Nos. 93.847, Diabetes,
identify the specific portions of the Special Emphasis Panel; NIDDK Clinical Endocrinology and Metabolic Research;
Trials in Diabetes. 93.848, Digestive Diseases and Nutrition
comment to be withheld from the public
Date: June 18, 2018. Research; 93.849, Kidney Diseases, Urology
record. See FTC Rule 4.9(c). Your and Hematology Research, National Institutes
Time: 9:00 a.m. to 10:00 a.m.
comment will be kept confidential only Agenda: To review and evaluate grant of Health, HHS)
if the General Counsel grants your applications. Dated: May 24, 2018.
request in accordance with the law and Place: National Institutes of Health, Two David D. Clary,
the public interest. Once your comment Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone Program Analyst, Office of Federal Advisory
has been posted on the public FTC Committee Policy.
website—as legally required by FTC Conference Call).
Contact Person: Elena Sanovich, Ph.D., [FR Doc. 2018–11560 Filed 5–29–18; 8:45 am]
Rule 4.9(b)—we cannot redact or Scientific Review Officer, Review Branch, BILLING CODE 4140–01–P
remove your comment from the FTC DEA, NIDDK, National Institutes of Health,
website, unless you submit a Room 7351, 6707 Democracy Boulevard,
confidentiality request that meets the Bethesda, MD 20892–2542, 301–594–8886, DEPARTMENT OF HEALTH AND
requirements for such treatment under sanoviche@mail.nih.gov. HUMAN SERVICES
FTC Rule 4.9(c), and the General Name of Committee: National Institute of
Counsel grants that request. Diabetes and Digestive and Kidney Diseases National Institutes of Health
Special Emphasis Panel; PAR–18–042:
The FTC Act and other laws that the Ancillary Studies to Major Ongoing Clinical National Heart, Lung, and Blood
Commission administers permit the Research Studies. Institute Notice of Closed Meeting
collection of public comments to Date: June 28, 2018.
consider and use in this proceeding as Time: 10:00 a.m. to 12:00 p.m. Pursuant to section 10(d) of the
appropriate. The Commission will Agenda: To review and evaluate grant Federal Advisory Committee Act, as
applications. amended, notice is hereby given of the
consider all timely and responsive Place: National Institutes of Health, Two
public comments that it receives on or following meeting of the NHLBI
Democracy Plaza, 6707 Democracy Institutional Training Mechanism
before June 29, 2018. For information on Boulevard, Bethesda, MD 20892 (Telephone Review Committee.
the Commission’s privacy policy, Conference Call).
The meeting will be closed to the
including routine uses permitted by the Contact Person: Dianne Camp, Ph.D.,
Scientific Review Officer, Review Branch, public in accordance with the
Privacy Act, see https://www.ftc.gov/ provisions set forth in sections
DEA, NIDDK, National Institutes of Health,
site-information/privacy-policy. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Room 7013, 6707 Democracy Boulevard,
Heather Hippsley, Bethesda, MD 20892–2542, 301–594–7682, as amended. The grant applications and
Acting Principal Deputy General Counsel.
campd@extra.niddk.nih.gov. the discussions could disclose
Name of Committee: National Institute of confidential trade secrets or commercial
[FR Doc. 2018–11503 Filed 5–29–18; 8:45 am]
Diabetes and Digestive and Kidney Diseases property such as patentable material,
sradovich on DSK3GMQ082PROD with NOTICES

BILLING CODE 6750–01–P Special Emphasis Panel; PAR–18–423: and personal information concerning
NIDDK Multi-Center Clinical Study individuals associated with the grant
Implementation Planning Cooperative applications, the disclosure of which
Agreements (U34 Clinical Trial Optional).
would constitute a clearly unwarranted
Date: July 2, 2018.
Time: 11:30 a.m. to 2:00 p.m. invasion of personal privacy.
Agenda: To review and evaluate Name of Committee: Heart, Lung, and
cooperative agreement applications. Blood Initial Review Group; NHLBI

VerDate Sep<11>2014 17:04 May 29, 2018 Jkt 244001 PO 00000 Frm 00087 Fmt 4703 Sfmt 4703 E:\FR\FM\30MYN1.SGM 30MYN1

Document Created: 2018-05-30 01:02:11
Document Modified: 2018-05-30 01:02:11

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		June 18, 2018.
FR Citation		83 FR 24803

83 FR 24803 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 104 (May 30, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health